Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC. Stalker M, Marmarelis M, Langer C, Cohen RB, et al. Clin Lung Cancer 2025;26:124-130.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stalker M, Marmarelis M, Langer C, Cohen RB, et al. Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC. Clin Lung Cancer 2025;26:124-130.
PMID: 39616007